| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.3 |